Collagen & Gelatin Market Size, Share & Trends Analysis By Source, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global collagen & gelatin market is projected to be worth USD 1396 million by 2030
According to SPER Market Research, the collagen & gelatin market estimated to reach USD 1396 million by 2030 with a CAGR of 6.8%. Diabetes is one of the leading metabolic disorders. Diabetes patients also may suffer from foot infections and wounds which require regenerative treatments for healing purpose.
Impact of COVID-19 on the Collagen & Gelatin Market
During the COVID-19 pandemic, lockdowns were imposed and services unrelated to coronavirus were either postponed or cancelled. Thus, collagen and gelatin market have suffered with the inception of the pandemic. Many manufacturers were unable to run the production plants due to lack of logistics and disruption of supply chains.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Source, By Application, By End User
Geographies covered
North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered
Advanced BioMatrix, Bioregen Technologies, Collagen Matrix, Inc., Collagen Solutions PLC, Collplant Biotechnologies, Cologenesis Healthcare Pvt Ltd, DermaRite Industries, LL, Eucare Pharmaceuticals Private Limited, Geistlich Pharma AG, Gelita AG, Integra Lifesciences, Jellagen, Matricel GmbH, MedSkin Solutions Dr. Suwelack AG, Meril Lifesciences, Nitta Gelatin Inc., PB Leiner, Rousselot, Royal DSM, Smith & Nephew, Symatese, Synerheal Pharmaceuticals, WEISHARDT, Xiamen Hyfine Gelatin, Zimmer Biomet
Driver: Rising prevalence of cancer, diabetes and chronic wounds
Due the rising prevalence of cancer and diabetes, incidence of complex wounds has also increased requiring higher medical expenses. In diabetes, about 15% of total patients suffer from diabetic foot. The increasing prevalence of such wounds is driving the growth of collagen & gelatin market for regenerative products as such grafts and matrices.
Restraints: Availability of substitutes
Many substitutes are available for collagen and gelatin such as cellulose, alginate, chitosan which offer better healing, regeneration and efficiency. These substitutes can be used in regenerative therapies. The availability of these substitutes can hinder the growth of collagen & gelatin market.
Opportunity: Acceleration of product development
With the implementation of 21st Century Cures Act in December 2016, the product development process has been accelerated. The fast-track approval process assists the novel regenerative medicines to fasten the approval process and be available to the patients. This also supports the research and development to provide more efficient and faster treatment options.
Challenge: Trend shift towards veganism
Many consumers from developed countries are adopting veganism as a lifestyle. Thus, they do not prefer to consume any product of animal origin. The developing countries are also slowly adopting this culture. This shift in overall change in lifestyle can pose significant challenge to the growth of this market.
Collagen & Gelatin Market by Source:
Based on source, market has been segmented into bovine, porcine and other sources
Collagen & Gelatin Market by Application:
Based on source, market has been segmented into Pharmaceutical, Food, Beverage, Cosmetic, Nutraceutical, Others
Collagen & Gelatin Market by End User:
Based on end user, the market is segmented into hospitals and surgical centres.
Hospitals have the largest share of this market by end user due to availability of skilled staff, advanced equipment and large number of surgeries performed at the hospitals.
Collagen & Gelatin Market by Region:
North America owns the largest share of this market owing to rising geriatric population and presence of leading players of collagen & gelatin market in this geographical area.
According to SPER Market Research, the collagen & gelatin market estimated to reach USD 1396 million by 2030 with a CAGR of 6.8%. Diabetes is one of the leading metabolic disorders. Diabetes patients also may suffer from foot infections and wounds which require regenerative treatments for healing purpose.
Impact of COVID-19 on the Collagen & Gelatin Market
During the COVID-19 pandemic, lockdowns were imposed and services unrelated to coronavirus were either postponed or cancelled. Thus, collagen and gelatin market have suffered with the inception of the pandemic. Many manufacturers were unable to run the production plants due to lack of logistics and disruption of supply chains.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Source, By Application, By End User
Geographies covered
North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered
Advanced BioMatrix, Bioregen Technologies, Collagen Matrix, Inc., Collagen Solutions PLC, Collplant Biotechnologies, Cologenesis Healthcare Pvt Ltd, DermaRite Industries, LL, Eucare Pharmaceuticals Private Limited, Geistlich Pharma AG, Gelita AG, Integra Lifesciences, Jellagen, Matricel GmbH, MedSkin Solutions Dr. Suwelack AG, Meril Lifesciences, Nitta Gelatin Inc., PB Leiner, Rousselot, Royal DSM, Smith & Nephew, Symatese, Synerheal Pharmaceuticals, WEISHARDT, Xiamen Hyfine Gelatin, Zimmer Biomet
Driver: Rising prevalence of cancer, diabetes and chronic wounds
Due the rising prevalence of cancer and diabetes, incidence of complex wounds has also increased requiring higher medical expenses. In diabetes, about 15% of total patients suffer from diabetic foot. The increasing prevalence of such wounds is driving the growth of collagen & gelatin market for regenerative products as such grafts and matrices.
Restraints: Availability of substitutes
Many substitutes are available for collagen and gelatin such as cellulose, alginate, chitosan which offer better healing, regeneration and efficiency. These substitutes can be used in regenerative therapies. The availability of these substitutes can hinder the growth of collagen & gelatin market.
Opportunity: Acceleration of product development
With the implementation of 21st Century Cures Act in December 2016, the product development process has been accelerated. The fast-track approval process assists the novel regenerative medicines to fasten the approval process and be available to the patients. This also supports the research and development to provide more efficient and faster treatment options.
Challenge: Trend shift towards veganism
Many consumers from developed countries are adopting veganism as a lifestyle. Thus, they do not prefer to consume any product of animal origin. The developing countries are also slowly adopting this culture. This shift in overall change in lifestyle can pose significant challenge to the growth of this market.
Collagen & Gelatin Market by Source:
Based on source, market has been segmented into bovine, porcine and other sources
Collagen & Gelatin Market by Application:
Based on source, market has been segmented into Pharmaceutical, Food, Beverage, Cosmetic, Nutraceutical, Others
Collagen & Gelatin Market by End User:
Based on end user, the market is segmented into hospitals and surgical centres.
Hospitals have the largest share of this market by end user due to availability of skilled staff, advanced equipment and large number of surgeries performed at the hospitals.
Collagen & Gelatin Market by Region:
North America owns the largest share of this market owing to rising geriatric population and presence of leading players of collagen & gelatin market in this geographical area.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Collagen & Gelatin Market
4.4. Market Trends
5. GLOBAL COLLAGEN & GELATIN MARKET, BY SOURCE, 2019-2030 (USD MILLION)
5.1. Bovine
5.2. Porcine
5.3. Other Sources
6. GLOBAL COLLAGEN & GELATIN MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Pharmaceutical
6.2. Food
6.3. Beverage
6.4. Cosmetic
6.5. Nutraceutical
6.6. Others
7. GLOBAL COLLAGEN & GELATIN MARKET, BY END USER, 2019-2030 (USD MILLION)
7.1. Hospitals
7.2. Surgical Centres
8. GLOBAL COLLAGEN & GELATIN MARKET, BY GEOGRAPHY, 2019-2030 (USD MILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Latin America
8.4.2. Middle East & Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Advanced BioMatrix
10.2. Bioregen Technologies
10.3. Collagen Matrix, Inc.
10.4. Collagen Solutions PLC
10.5. Collplant Biotechnologies
10.6. Cologenesis Healthcare Pvt Ltd
10.7. DermaRite Industries, LL
10.8. Eucare Pharmaceuticals Private Limited
10.9. Geistlich Pharma AG
10.10. Gelita AG
10.11. Integra Lifesciences
10.12. Jellagen
10.13. Matricel GmbH
10.14. MedSkin Solutions Dr. Suwelack AG
10.15. Meril Lifesciences
10.16. Nitta Gelatin Inc.
10.17. PB Leiner
10.18. Rousselot
10.19. Royal DSM
10.20. Smith & Nephew
10.21. Symatese
10.22. Synerheal Pharmaceuticals
10.23. WEISHARDT
10.24. Xiamen Hyfine Gelatin
10.25. Zimmer Biomet
11. APPENDIX
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Collagen & Gelatin Market
4.4. Market Trends
5. GLOBAL COLLAGEN & GELATIN MARKET, BY SOURCE, 2019-2030 (USD MILLION)
5.1. Bovine
5.2. Porcine
5.3. Other Sources
6. GLOBAL COLLAGEN & GELATIN MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Pharmaceutical
6.2. Food
6.3. Beverage
6.4. Cosmetic
6.5. Nutraceutical
6.6. Others
7. GLOBAL COLLAGEN & GELATIN MARKET, BY END USER, 2019-2030 (USD MILLION)
7.1. Hospitals
7.2. Surgical Centres
8. GLOBAL COLLAGEN & GELATIN MARKET, BY GEOGRAPHY, 2019-2030 (USD MILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Latin America
8.4.2. Middle East & Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Advanced BioMatrix
10.2. Bioregen Technologies
10.3. Collagen Matrix, Inc.
10.4. Collagen Solutions PLC
10.5. Collplant Biotechnologies
10.6. Cologenesis Healthcare Pvt Ltd
10.7. DermaRite Industries, LL
10.8. Eucare Pharmaceuticals Private Limited
10.9. Geistlich Pharma AG
10.10. Gelita AG
10.11. Integra Lifesciences
10.12. Jellagen
10.13. Matricel GmbH
10.14. MedSkin Solutions Dr. Suwelack AG
10.15. Meril Lifesciences
10.16. Nitta Gelatin Inc.
10.17. PB Leiner
10.18. Rousselot
10.19. Royal DSM
10.20. Smith & Nephew
10.21. Symatese
10.22. Synerheal Pharmaceuticals
10.23. WEISHARDT
10.24. Xiamen Hyfine Gelatin
10.25. Zimmer Biomet
11. APPENDIX
